A Pilot Study of the Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making
The Impact of the Patient Activated Learning System (PALS) on Knowledge Acquisition, Recall, and Decision Making About Antihypertensive Medication: A Pilot Study
1 other identifier
interventional
118
1 country
1
Brief Summary
This is a randomized pilot study comparing the impact of the Patient Activated Learning System (PALS) on knowledge acquisition, recall, and decision making about antihypertensive medication compared to an established online health information system (WebMD). We will also compare the two systems with regard to user experience measures such as understandability and trust.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2017
CompletedStudy Start
First participant enrolled
April 15, 2017
CompletedFirst Posted
Study publicly available on registry
May 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedApril 23, 2019
April 1, 2019
9 months
March 15, 2017
April 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knowledge acquisition
Subjects will be asked questions about the materials they viewed.
Immediate
Secondary Outcomes (3)
Recall
1 week
User experience
Immediate
Decision making
Immediate
Study Arms (2)
PALS
EXPERIMENTALParticipants will view materials about the antihypertensive, chlorthalidone on the Patient Activated Learning System (PALS).
WedMD
ACTIVE COMPARATORParticipants will view materials about the antihypertensive, chlorthalidone on WebMD.
Interventions
Eligibility Criteria
You may qualify if:
- Weill Cornell Internal Medicine Associates (WCIMA) patients with hypertension who have been prescribed any antihypertensive medicine except chlorthalidone.
- Patients who meet the criteria above and are English speaking and without cognitive impairment or other medical condition that would impair or preclude their ability to participate (such as a serious medical condition).
You may not qualify if:
- WCIMA patients without hypertension
- WCIMA patients with hypertension who have not been prescribed antihypertensive medicine
- Patients who are non-English speaking
- Patients with cognitive impairment or other medical condition that would impair or preclude their ability to participate (such as a serious medical condition).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Internal Medicine Associates
New York, New York, 10021, United States
Related Publications (1)
Carmel AS, Cornelius-Schecter A, Frankel B, Jannat-Khah D, Sinha S, Pelzman F, Safford MM. Evaluation of the Patient Activated Learning System (PALS) to improve knowledge acquisition, retention, and medication decision making among hypertensive adults: Results of a pilot randomized controlled trial. Patient Educ Couns. 2019 Aug;102(8):1467-1474. doi: 10.1016/j.pec.2019.03.001. Epub 2019 Mar 4.
PMID: 30928344DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda S Carmel, MD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The statistician will be masked to the group assignment.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2017
First Posted
May 17, 2017
Study Start
April 15, 2017
Primary Completion
December 31, 2017
Study Completion
December 31, 2017
Last Updated
April 23, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share